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Introduction
The head-up tilt table test (HUT) has emerged as an important diagnostic method for the identification of individuals whose syncope is likely to be neurally mediated in origin. 1, 2 It is proposed that in neurally mediated syncope, a Bezold-Jarisch (B-J)-like reflex may be triggered by a small ventricle combined with vigorous systolic contraction under exaggerated sympathetic stimulation just before the episodes of syncope. The afferent end of this reflex may be mediated by left ventricular or right atrial mechanoreceptors that are activated during vigorous contraction around underfilled chambers in a situation similar to severe hemorrhage. Information from these mechanoreceptors travels along vagal afferent C fibers to the brain stem, which mediates the efferent response, primarily the withdrawal of sympathetic vasomotor tone (vasodepression) and often a vagally mediated bradycardia (cardioinhibition). 3−5 Clinically, B-J reflex is also implicated in the episodes of hypotension and/or bradycardia in many other conditions including acute inferoposterior wall myocardial infarction, coronary arteriography, coronary reperfusion after thrombolytic therapy, and exertional syncope in aortic stenosis 3, 5, 7, 8 It is known that type C fibers can also respond to various mechanical and chemical stimuli, including veratum alkaloids and vasoactive hormones or metabolites released during myocardial ischemia. 7 In patients with normal coronary angiograms, myocardial ischemia could be the result of either marked increase of metabolic demands owing to the vigorous contraction of the left ventricle or dynamic coronary microvascular insufficiency, or both.
9−11 Both of the above might be induced by exaggerated sympathetic stimulation and may theoretically initiate a B-J-like reflex followed by episodes of neurally mediated syncope (including vasodepressor, cardioinhibitory, and mixed type). Recent clinical evidence does suggest that myocardial ischemia might occur in patients with neurally mediated syncope and normal coronary angiograms. 12, 13 However, it is not known whether this is just a coincidence or whether there is a causal link. It is also not known whether coronary microvascular function is really impaired in patients with neurally mediated syncope, or if it is, whether this impairment is also present in PACE, Vol. 26 other forms of syncope. Thus, to evaluate if coronary microvascular dysfunction is associated with neurally mediated syncope, the present study was conducted to examine HUT results and coronary hemodynamics in a series of patients with recurrent syncope.
Patients and Methods Patient Population
Thirty-two consecutive patients with recurrent syncope were initially included. All of them previously had two or more episodes of clinical syncope with evident consciousness loss in different conditions within the 30 months leading up to the study. The other symptoms associated with the episodes of syncope included chest tightness, abdominal pain, vertigo, cold sweating, palpitation, and nausea. Patients with a history of coronary artery disease, unstable angina, myocardial infarction, congestive heart failure, documented ventricular arrhythmia, established hypertension (blood pressure ≥160/95 mmHg), diabetes mellitus, and other systemic diseases were excluded from the study. The study protocol was reviewed and approved by the hospital ethical committee. All patients gave their written consent before entering the study.
Systemic Evaluations
In each patient, all medications were discontinued for ≥5 days before the workup for possible cardiac and noncardiac causes of syncope. They undertook a complete hematological and urinary and blood chemistry studies in a drug-free status to rule out anemia and other systemic or metabolic disorders. They were interviewed and examined by an experienced neurologist to evaluate if there were psychiatric or neurological disorders. Psychiatric consultation was taken where indicated in individual cases. Computerized tomography of the brain, carotid Doppler scanning, and electroencephalography were also done in selected patients as indicated. Every patient underwent careful physical examination followed by chest X rays, echocardiography, and 24-hour Holter electrocardiographic (ECG) monitoring to detect possible organic heart diseases and significant arrhythmia. Electrophysiological studies were then conducted if the possibility of cardiac arrhythmia could not be excluded as the cause of syncope.
Treadmill Exercise Test
In every patient, treadmill exercise tests were done with the symptom-limited modified Bruce protocol which the authors have reported before. 14 Medication other than sublingual nitroglycerin was prohibited for ≥5 days prior to the treadmill exercise test (TET). The result was considered positive for myocardial ischemia when there was ≥1 mm horizontal or downsloping depression of the ST segment 80 ms after the J point in at least two adjacent ECG leads. The results of the TETs were independently evaluated by two cardiologists who did not know the patients' clinical history and the findings of coronary angiograms.
HUT
Within 48 hours after the TETs, HUTs were performed in the morning hours after an overnight fasting. The protocol of the HUT used in this study has been described by the authors before. 15, 16 In general, patients received HUTs after an overnight fasting during hospitalization. A 7 Fr Swan-Ganz catheter (Baxter Healthcare Corp., Puerto Rico) was inserted via the right internal jugular vein into a wedge position. An intraarterial line was established on the nondominant (usually left) arm for continuous monitoring of blood pressure. After the patients were relaxed in a supine position for 15 minutes at room temperature (21
• C-23
• C), the baseline hemodynamics were recorded. Patients were first tilted to an angle of 30 degrees with footplate support for 30 minutes. They were then tilted to an angle of 60 degrees for another 30 minutes. In patients who had no syncope during HUT at an angle of 60 degrees, the above procedure would be repeated under additional isoproterenol intravenous infusion in titrated doses (1-5 µg/min). The patients were laid horizontally for 15 minutes between each stage of HUT. The result of the HUT was considered positive if the patients completely lost their consciousness (syncope) or had episodes of consciousness change and general weakness with a systolic blood pressure <50 mmHg (near-syncope) with or without isoproterenol infusion. When a positive result was obtained, the study was stopped, normal saline was infused, and the patients were immediately put in a foot up position to regain their blood pressure. All patients were continuously monitored for 15 minutes after their systemic hemodynamics were returned to normal status.
Patients were then divided into two groups according to the results of clinical evaluations and the HUT. Patients who had identified cause(s) for their syncope and negative HUT were defined to be with "syncope of other cause." Patients who had no identifiable cause for their syncope and a positive HUT were considered to have neurally mediated syncope.
Coronary Angiograms and Coronary Hemodynamic Studies
Coronary angiogram and coronary hemodynamic studies were performed in a drug-free status in each patient within 3 days of the HUT by another team of staff who were unaware of the results of the HUT. The protocol was similar to one that the authors have reported before.
14 In brief, coronary angiograms were performed by the standard Judkins method via the right femoral approach in the morning after an overnight fasting. At least four standard views of coronary angiograms were obtained. The severity of coronary stenosis was measured by electronic calipers on an on-line quantitative coronary imaging system (Phillips, Shelton, CT, USA). Any lesion with ≥50% stenosis of coronary luminal diameter in one or more standard views was considered significant for coronary artery disease.
In patients with completely normal coronary angiograms, ergonovine challenge tests were performed by sequential intravenous doses of 0.05 mg, 0.10 mg, and 0.25 mg, separated by 2-minute intervals, up to a total of 0.4 mg. Coronary artery spasm was defined as significant coronary vasoconstriction (≥50% reduction of luminal diameter) shown by angiograms in conjunction with anginal attack, ischemic-like ST-segment deviation, or both, after each dose of ergonovine. Nitroglycerin (0.3 mg) was given intracoronarily 5 minutes after the last dose of ergonovine or immediately after the onset of coronary spasm. Patients who had even insignificant coronary artery disease or evidence for epicardial coronary artery spasm were excluded from the study.
Coronary hemodynamic studies were conducted 15 minutes after a negative result of the ergonovine challenge test was obtained. A 7 Fr Baim thermodilution coronary sinus flow (CSF) catheter (Electro-catheter Corp., Rahway, NJ, USA) was inserted via the right internal jugular vein, and positioned in the great cardiac vein with the tip wedged into the junction of great cardiac vein and anterior interventricular vein. Correct placement was documented by the injection of a small amount (3-5 cc) of contrast medium via the end hole of the catheter and recorded on cine film. After the patient's condition stabilized, 50 cc of room temperature saline was infused through the thermodilution catheter at a constant speed of 50 mL/min by Harvard pump (Harvard Apparatus, South Natick, MA, USA). Using the thermodilution method, both CSF (milliliters/minute) and great cardiac venous flow (GCVF) (milliliters/minute) were measured simultaneously at baseline and every 4 minutes after an intravenous infusion of dipyridamole (0.56 mg/kg body weight for 4 minutes) for at least 12 minutes. At baseline, CSF and GCVF were measured at least three times to evaluate the range of error. The data was taken as the mean of the last three measurements only if their range of error was <10%. The maximum CSF and GCVF were then defined as the peak value in this series of measurements. In each case, hemoglobin and oxygen content of the great cardiac venous blood were checked. The parameters of systemic hemodynamics including heart rate, blood pressure, rate-pressure product, cardiac index (by Fick method), and stroke volume index were also obtained. Coronary flow reserve (CFR) was defined as the maximal GCVF or CSF divided by the baseline counterparts. Coronary vascular resistance (CVR) was calculated by the formula of mean arterial blood pressure divided by CSF or GCVF.
Another ten subjects (6 men, 4 women; age 33-70 years) with atypical chest pain, normal coronary angiograms, negative TETs, and no history of fainting or syncope also received coronary hemodynamic studies for control ( Figs. 1 and 2 ).
Statistical Analysis
All data is expressed as mean ± SD. The data of systemic and coronary hemodynamics before and after dipyridamole infusion were compared by two-tailed paired Student's t-test in each patient group and in the control group. The difference among the three groups was evaluated by repeated measures ANOVA or the chi-square test. Scheffe's test was then used for multiple comparisons following ANOVA. A P value <0.05 was considered statistically significant.
Results

Patient Characteristics
Among the 32 patients initially included, only 30 (16 men, 14 women; age 22-73 year, mean 48 ± 20 years) completed the whole study and comprised the study group. Of these, 15 patients (11 men, 4 women; age 26-66 years) had a negative HUT even with isoproterenol infusion. Their episodes of syncope could be related to paroxysmal atrial fibrillation (n = 3), idiopathic ventricular tachycardia (n = 2), sick sinus syndrome (n = 2), paroxysmal junctional tachycardia (n = 1), postural hypotension (n = 2), transient ischemic attack (n = 2), focal seizure (n = 1), and psychosomatic (n = 2). They were then defined to have "syncope of other cause." The other 15 patients (7 men, 8 women; age 22-73 years) with no identifiable cause for their syncope had a positive HUT. They were suggested to have neurally mediated syncope. Among them, nine patients developed syncope and four had episodes of nearsyncope with a systolic blood pressure < 50 mmHg spontaneously during HUT. The other two patients developed syncope during the isoproterenol infusion (1 and 2 µg/min, respectively). All these patients claimed that the symptoms developed during the test were similar to those that had happened during previous syncopal episodes. Overall, nine patients developed mixed or cardioinhibitory syncope with marked hypotension (systolic blood pressure <50 mmHg) and bradycardia (heart rate <50 beats/min) during HUT, the other six patients had only hypotension at the episode of syncope (vasodepressor syncope). Table I shows baseline characteristics in patients with a positive HUT (neurally mediated syncope), those with negative HUT (syncope of other cause), and control subjects. There were no sig- nificant differences in age, sex, and left ventricular ejection fraction measured by the radionuclide method among the three groups. Subgroup analysis shows that these differences were also insignificant between patients with mixed or cardioinhibitory syncope and those with vasodepressor syncope.
TET
Exercise induced myocardial ischemia was more frequently seen in patients with a positive HUT (three with mixed or cardioinhibitory syncope and three with vasodepressor syncope) than in the other two groups (Table I ). The only patient with positive TET and negative HUT turned out to be a victim of sick sinus syndrome. Table II shows systemic hemodynamics at baseline and after dipyridamole infusion. At baseline the heart rate, systolic blood pressure, ratepressure product, cardiac index, and stroke volume index did not differ significantly among the three groups. After dipyridamole infusion, both heart rate and cardiac index were significantly increased, while systolic blood pressure was reduced, in all three groups. Rate-pressure product, an index of cardiac work, was significantly increased by dipyridamole infusion in those patients with a negative HUT and control subjects but not in the patients with a positive HUT. Subgroup analysis shows that rate-pressure product and stroke volume index tended to be higher after dipyridamole infusion in patients with vasodepressor syncope as compared with those with mixed or cardioinhibitory syncope. *B versus D, P < 0.05; **B versus D, P < 0.01. B = baseline; CI = cardiac index; D = after intravenous dipyridamole infusion; HR = heart rate; HUT = head-up tilt test; NS = not significant; SBP = systolic blood pressure; SVI = stroke volume index. Table III shows coronary blood flow at baseline and after dipyridamole infusion. Baseline GCVF and CSF did not differ significantly between patients with positive and those with negative HUT. After dipyridamole infusion, maximum CSF and CFR, derived from CSF or from GCVF, were significantly lower in patients with a positive HUT than in those with a negative HUT. There was no significant difference in any of the above parameters between patients with negative HUT and control subjects. There was also no significant difference in coronary hemodynamics between patients with mixed or cardioinhibitory syncope and those with vasodepressor syncope as measured by subgroup analysis. Table IV gives the calculated CVR, derived from GCVF or CSF, at baseline and after dipyridamole infusion in the three groups. Baseline CVR measurements were similar between patients with positive and those with negative HUT. However, the ratio of CVR at baseline to that after dipyridamole infusion was significantly lower in the former than in the latter group. There was no significant difference in any of the above parameters between patients with negative HUT and control subjects.
Systemic Hemodynamics Before and After Dipyridamole Infusion
Coronary Blood Flow Before and After Dipyridamole Infusion
CVR Before and After Dipyridamole Infusion
Discussion
The major finding of the present study is that exercise induced myocardial ischemia was more frequently seen in syncopal patients with positive HUT than in those with negative HUT. Furthermore, compared with that in control subjects, CFR was significantly reduced in the former group but preserved in the latter, suggesting coronary microvascular function was exclusively impaired in those patients with neurally mediated syncope. Apart from individual case reports, 12, 13 this is the first study systematically demonstrating that coronary microvascular function was impaired in patients with neurally mediated syncope. Although the pathogenesis is still not fully explored, the results of the present study may highlight the potential importance of coronary microvascular dysfunction in the development of neurally mediated syncope.
Subclinical Myocardial Ischemia Owing to Coronary Microvascular Dysfunction in Neurally Mediated Syncope
It has been shown by the authors 14 and many other investigators 9, 10, 17 that coronary microvascular dysfunction may contribute to episodes of angina pectoris and/or clinical myocardial ischemia while epicardial coronary arteries are patent. It is also known that coronary microvascular function measured by different methods might be impaired in various clinical conditions including hypertension, hyperlipidemia, diabetes mellitus, left ventricular hypertrophy, and cardiomyopathy, 18 suggesting the common existence of coronary microvascular dysfunction in various cardiovascular diseases.
In the present study, none of the patients with positive HUT (neurally mediated syncope) had left ventricular hypertrophy, dilated left ventricle, cardiomyopathy, diabetes mellitus, hypercholesterolemia, or any other detected systemic diseases. Though coronary angiograms were normal, an ischemic-like ECG was found during TETs, suggesting the presence of exercise induced myocardial ischemia owing to coronary microvascular insufficiency 14 in 40% of the study group. Furthermore, different from that in patients with syncope of other causes and control subjects, cardiac work indexed by rate-pressure product failed to increase sufficiently after dipyridamole infusion, possibly owing to inadequate myocardial perfusion with limited coronary microvascular dilatation, in patients with neurally mediated syncope. It seems that in this group of patients, myocardial ischemia, though subclinical in the majority, was primarily related to dynamic coronary microvascular dysfunction rather than to other cardiovascular disorders.
Possible Role of Coronary Microvascular Dysfunction in Neurally Mediated Syncope
It has been suggested that in neurally mediated syncope, a B-J reflex may be triggered by a small ventricle combined with vigorous systolic contraction preceding the episodes of syncope. [3] [4] [5] 7 However, the exact mechanism of neurally mediated syncope is still not clear, partly owing to the lack of proof of a direct initiator, if any, of the B-J reflex in these patients. One of the possibilities is that multifactorial rather than single mechanisms contribute to the episodes of syncope. This concept is supported by clinical observations that multiple stimuli, like pain, fear, psychological stress, use of vasodilators, gastrointestinal hemorrhage, 3, 5, 7, 8 and myocardial ischemia, 12,13 may trigger an uniform vasodepressor response.
Recently, accumulating evidence suggests numerous "exaggerated" neurohumoral responses just preceding or during the episodes of syncope in HUT. 19−21 It was shown that in patients with neurally mediated syncope, autonomic tone, assessed by heart rate variability, was abnormally altered with parasympathetic withdrawal and consequently shifted toward sympathetic activity just prior to syncope. 20, 21 This is quite similar to what is seen in serial changes of heart rate variability preceding the ischemic episodes in patients with coronary microvascular dysfunction. 22, 23 It has also been demonstrated that coronary microvascular insufficiency can be dynamically enhanced by sympathomimic agents in some of these patients. 12 The authors speculate that in patients with neurally mediated syncope, autonomic tone is abnormally altered and coronary microvascular insufficiency is dynamically enhanced, which limits coronary blood flow and potentiates regional myocardial ischemia just before the onset of syncope.
It has been suggested that both the chemical stimulation of vasoactive substances or metabolites from myocardial ischemia and the mechanical stimulation from the vigorous contraction of the left ventricle during HUT may initiate a B-J-like reflex leading to cardiovascular inhibition. 19 Recently, Pomidossi et al. 24 found that arterial baroreflex after vasodilator infusion was transiently impaired at episodes of myocardial ischemia, either symptomatic or silent, in patients with coronary artery disease. Thus, cardiovascular inhibition could be initiated and/or augmented by regional myocardial ischemia in different occasions. In the present study, no patients developed syncope after dipyridamole infusion. However, the rate-pressure product failed to increase adequately by dipyridamole infusion in patients with neurally mediated syncope. While myocardial perfusion might be regionally limited, the impairment of cardiac performance could be related to myocardial ischemia itself, or to transient cardiovascular inhibition owing to a B-J-like reflex potentiated by myocardial ischemia, or both. The findings from the present study are compatible with the hypothesis that myocardial ischemia associated with coronary microvascular dysfunction may potentiate the B-J-like reflex and contribute to the episodes of syncope in patients with neurally mediated syncope. 12 It was recently shown that arterial blood flow in the forearm failed to respond adequately to vasodilator infusion in patients with neurally mediated syncope. 25 This finding, combined with the results of the present study, highlights the possible existence of systemic microvascular dysfunction in these patients.
Study Limitations
In the present study, coronary hemodynamics were measured invasively in all patients within 3 days of HUT. To confirm if coronary blood flow is insufficient during episodes of syncope, it is better to evaluate coronary hemodynamics simultaneously during the HUT. Noninvasive studies like positron emission tomography might be helpful to measure the changes of myocardial perfusion under these conditions. 26, 27 Recently, Ascheim et al., 12 by using myocardial perfusion scan and echocardiogram, demonstrated the presence of anterior-lateral hypoperfusion corresponding with anterior-lateral hypokinesis preceding syncope during HUT in a patient with coronary microvascular angina. It seems that coronary microvascular dysfunction is a contributor to rather than a sequela of syncope itself. In addition, coronary hemodynamics and coronary microvascular function were similarly impaired in patients with mixed or cardioinhibitory syncope and those with vasodepressor syncope. It seems that coronary microvascular insufficiency, like other stimulants, is one of the common initiators in different types of neurally mediated syncope. It is still unknown if the severity of cardiac suppression is related to the extent of myocardial ischemia induced by dynamic coronary microvascular insufficiency during HUT. It would be interesting to see if patients with more impaired coronary microvascular function are more prone to syncope during HUT.
Conclusions
As compared with those with negative HUT, exercise induced myocardial ischemia was more frequently seen, and coronary microvascular function was impaired mainly, in patients with positive HUT. While the pathogenesis is still not clarified, the results of the present study highlight the potential importance of coronary microvascular dysfunction as one of the contributing factors in the development of neurally mediated syncope. The results may have potential clinical implications. The authors and other investigators have recently shown that in patients with coronary microvascular dysfunction, myocardial ischemia can be improved by medications including nitrate-potassium channel opener 23 and PACE, Vol. 26
angiotensin-converting enzyme inhibitor. 28 While coronary microvascular insufficiency might contribute to episodes of neurally mediated syncope, medication that could improve coronary microvascular function may theoretically prevent or reduce episodes of syncope, especially in patients with positive TET. Future study is necessary to clarify this issue.
